Related Experiment Video

Updated: Jun 17, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Andrographolide inhibits hepatoma cells growth and affects the expression of cell cycle related proteins

Kai-Kai Shen1, Tian-Yu Liu, Chong Xu

  • 1Key Laboratory of Standardization of Chinese Medicines of Ministry of Education, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|January 9, 2010
PubMed

Insights

Andrographolide (Andro) inhibits hepatoma cell growth and colony formation without affecting normal liver cells. This compound impacts cell cycle proteins, suggesting a potential mechanism for its anti-cancer effects.

Area of Science:

  • Pharmacology
  • Cancer Biology
  • Hepatocellular Carcinoma Research

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Identifying novel therapeutic agents with targeted toxicity is crucial for effective cancer treatment.
  • Andrographolide, a natural compound, has shown potential anti-cancer properties requiring further investigation.

Purpose of the Study:

  • To investigate the toxic effects of andrographolide (Andro) on hepatoma cells.
  • To elucidate the preliminary mechanisms underlying Andro's action on cancer cells.
  • To assess Andro's selectivity towards hepatoma cells versus normal liver cells.

Main Methods:

  • Cell viability was assessed using the MTT assay.
  • Colony formation assays were performed on hepatoma cell lines (Hep3B and HepG2).
  • Cell cycle analysis via flow cytometry and Western blotting for cell cycle-related proteins (Cdc-2, p-Cdc-2, Cyclin B, Cyclin D1) were conducted.

Main Results:

  • Andrographolide demonstrated dose-dependent inhibition of hepatoma cell growth and colony formation.
  • Andro exhibited no significant toxicity towards normal human liver L-02 cells.
  • Flow cytometry revealed Andro induced G0-G1 phase reduction and G2-M phase accumulation in Hep3B cells.
  • Western blotting indicated a time-dependent decrease in Cdc-2, p-Cdc-2, Cyclin D1, and Cyclin B protein expression.

Conclusions:

  • Andrographolide specifically inhibits the proliferation of hepatoma cells.
  • The anti-proliferative effects of Andro are associated with the modulation of cell cycle regulatory proteins.
  • Andro represents a potential therapeutic candidate for hepatocellular carcinoma treatment.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Generation and Single-Cell Transcriptomic Analysis of Hepatocellular Carcinoma Organoids following Drug Treatment08:18

Generation and Single-Cell Transcriptomic Analysis of Hepatocellular Carcinoma Organoids following Drug Treatment

Published on: May 26, 2026

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...